Biotech Essentials

Career and Jobs

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 17.06.2021.

#COVID19
#patients
#VentureCapital
#LifeSciences
#biotechnology
#moversandshakers
#pharmaceuticals
#COVIDvaccine
#pfizer

Career And Jobs

@MassBio shared
On Jun 16, 2021
From the development of #COVID19 vaccines to record-breaking #VentureCapital investment & lab growth, the MA #LifeSciences cluster continues to prove itself as the best place in the world for #patients & science. @BostonGlobe explores how: https://t.co/zPSP1lQQOc
Open
Life sciences is poised to be Boston’s dominant industry. Has the area become the Silicon Valley of biotech?

Life sciences is poised to be Boston’s dominant industry. Has the area become the Silicon Valley of biotech?

Since December, you can find six major indications that Boston is the undisputed center of the life sciences industry, a place where ideas and products that change — and save — people’s ...

@Biotechnology shared
On Jun 11, 2021
BioSpace Movers & Shakers, June 11 https://t.co/PJUt4gWxeJ https://t.co/Qpp9lUKaXZ
Open
BioSpace Movers & Shakers, June 11

BioSpace Movers & Shakers, June 11

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

@BIOConvention shared
On Jun 15, 2021
RT @DrMichelleBIO: It is my pleasure to present the 2021 @IAmBiotech Governor of the Year Award to Maryland Governor Larry Hogan. Thank you,@GovLarryHogan, for your leadership and commitment to advancing biotechnology and promoting public health. https://t.co/iPfaMyEVcg https://t.co/671HNXMG9W
Open
Maryland Governor Larry Hogan Named BIO’s Governor of the Year

Maryland Governor Larry Hogan Named BIO’s Governor of the Year

Today, the Biotechnology Innovation Organization (BIO) presented Maryland Governor Larry Hogan with its 2021 Governor of the Year Award. Governor Hogan received the award virtually at BIO ...

@BIOConvention shared
On Jun 14, 2021
RT @nkartatx: We’re thrilled to announce that Nkarta CEO Paul Hastings has been elected as Chair of the BIO Board of Directors – read more: https://t.co/La9ayQmtx2 @IAmBiotech https://t.co/tCJh5iAREM
Open
BIO Elects Paul Hastings as New Board Chair

BIO Elects Paul Hastings as New Board Chair

New Officers Join BIO’s Governing Boards  

@pharminews shared
On Jun 15, 2021
Top Ten Biotech Companies in Germany https://t.co/mmDxSrIWHi Germany’s biotechnology industry is booming, with research by Germany Trade & Invest showing that the biotech workforce in the country has passed the 50,000 mark, with employees working across 660 dedicated biotech com https://t.co/k7IuY7rwRi
Open
Top Ten Biotech Companies in Germany

Top Ten Biotech Companies in Germany

Germany’s biotechnology industry is booming, with research by Germany Trade & Invest showing that the biotech workforce in the country has passed the 50,000 mark, with employees working ...

@JohnCendpts shared
On Jun 14, 2021
Looking beyond the pandemic, Moderna appoints J&J veteran Paul Burton as new CMO $MRNA By @ZacharyBrennan https://t.co/8CboxrfwHw
Open
Looking beyond the pandemic, Moderna appoints J&J veteran Paul Burton as new CMO

Looking beyond the pandemic, Moderna appoints J&J veteran Paul Burton as new CMO

Moderna is turning to one of its Covid-19 vaccine competitors to fill its open CMO slot, but this time, it's not the vaccine experience they're after. Paul Burton, who's spent 16 years at ...

@biospace shared
On Jun 16, 2021
How Biotech saved the world: Pfizer CEO opens up and shares what’s next #pfizer #COVIDvaccine https://t.co/bXsavPaVf8
Open
How Biotech Saved the World: Pfizer CEO Opens Up and Shares What’s Next

How Biotech Saved the World: Pfizer CEO Opens Up and Shares What’s Next

A sense of urgency, powerful science, relentless ingenuity, hope and trust drove the development of Pfizer and BioNTech’s mRNA vaccine during the height of the COVID-19 pandemic. As the ...

@JohnCendpts shared
On Jun 14, 2021
Hal Barron gambles $625M cash on high-wire TIGIT act, throwing GlaxoSmithKline into heated race and completing next-gen I/O trinity By @AmberTongPW $GSK https://t.co/aKtykkZdIh
Open
Hal Barron gambles $625M cash on high-wire TIGIT act, throwing GlaxoSmithKline into heated race and completing next-gen I/O trinity

Hal Barron gambles $625M cash on high-wire TIGIT act, throwing GlaxoSmithKline into heated race and completing next-gen I/O trinity

Count Hal Barron and GlaxoSmithKline in for the TIGIT fight. The stakes are as high as the risks: While a growing pack of Big Pharma rivals is lending credence to the hypothesis that TIGIT ...